Terns Pharmaceuticals, Inc.

BST:430 Stock Report

Market Cap: €180.3m

Terns Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

BST:430 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Apr 24Sell€2,020,608Vivo Capital, LLCCompany329,121€6.45
30 Nov 23Buy€2,575Mark VignolaIndividual743€3.47
30 Nov 23Buy€2,575Seokho YoonIndividual743€3.47
31 May 23Buy€2,793Senthil SundaramIndividual2,111€1.32
31 May 23Buy€13,226Seokho YoonIndividual9,997€1.32
31 May 23Buy€13,226Mark VignolaIndividual9,997€1.32

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 430?
Owner TypeNumber of SharesOwnership Percentage
General Public64,4690.171%
Individual Insiders308,6820.821%
Hedge Funds2,050,0005.45%
Institutions13,962,29537.1%
VC/PE Firms21,228,38356.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.7%.


Top Shareholders

Top 25 shareholders own 97.99% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.9%
OrbiMed Advisors LLC
7,481,204€35.9m97.3%0.6%
15.7%
Vivo Capital, LLC
5,899,372€28.3m121%2.41%
12.7%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
4,781,566€22.9m0%4.72%
8.15%
VR Adviser, LLC
3,066,241€14.7m0%1.95%
5.45%
Fairmount Funds Management LLC
2,050,000€9.8m0%1.71%
4.94%
Deerfield Management Company, L.P. Series C
1,860,000€8.9m-20.7%0.25%
4.69%
BML Capital Management, LLC
1,764,274€8.5m0%10.63%
3.75%
Shanghai Liyi Investment Management Partnership (Limited Partnership)
1,411,206€6.8m0%3.16%
3.35%
RA Capital Management, L.P.
1,261,435€6.0m0%0.12%
3.29%
Suvretta Capital Management, LLC
1,238,800€5.9m0%0.21%
2.33%
Antara Capital LP
874,600€4.2m-18.6%0.71%
1.9%
Decheng Capital LLC
714,285€3.4m0%1.17%
1.86%
Ikarian Capital, LLC
700,000€3.4m0%1.13%
1.75%
Barclays PLC Private Banking & Investment Banking Investment
658,222€3.2m4,920%0.01%
1.34%
Point72 Asset Management, L.P.
502,428€2.4m306%0.01%
1.07%
Affinity Asset Advisors, LLC
401,268€1.9m0%1.14%
0.98%
The Vanguard Group, Inc.
367,529€1.8m-15.1%no data
0.86%
Armistice Capital LLC
323,016€1.5m0%0.04%
0.77%
Samsara BioCapital LLC
289,068€1.4m0%0.3%
0.76%
Weidong Zhong
285,714€1.4m0%no data
0.74%
Millennium Management LLC
277,688€1.3m214%no data
0.56%
Driehaus Capital Management LLC
210,074€1.0m499%0.01%
0.49%
Renaissance Technologies LLC
184,416€883.8k172%no data
0.4%
BlackRock, Inc.
149,528€716.6k-79.7%no data
0.28%
Boothbay Fund Management, LLC
106,712€511.4k0%0.02%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.